Tissue Engineering: Future Perspectives

Mark E. Furth, Anthony Atala

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Tissue engineering combines the principles of materials and cell transplantation to develop substitute tissues and/or promote endogenous regeneration. The approach was initially conceived to address the critical gap between the growing number of patients on the waiting list for organ transplantation, but it will focus increasingly on prevalent conditions in which the restoration of functional tissue would answer a currently unmet medical need. Significant progress has been realized since its inception, but to date only a handful of complex products incorporating cells together with scaffolds have gained regulatory approval, and these have only achieved limited market penetration. Nonetheless, recent clinical reports with multiple years of patient follow-up document the maturation of the field and validate the development of neo-tissues and neo-organs, and the industry is rapidly becoming economically robust. The combination of advances in both clinical development and commercialization indicates that these technologies will reach increasing numbers of patients in the years to come.

Original languageEnglish
Title of host publicationPrinciples of Tissue Engineering: Fourth Edition
PublisherElsevier Inc.
Pages83-123
Number of pages41
ISBN (Print)9780123983589
DOIs
StatePublished - Nov 1 2013
Externally publishedYes

Fingerprint

Tissue Engineering
Tissue engineering
Tissue
Transplantation (surgical)
Technology Transfer
Waiting Lists
Cell Transplantation
Organ Transplantation
Scaffolds
Restoration
Regeneration
Industry

Keywords

  • Biomaterial
  • Cell-seeded scaffold
  • Decellularized tissue
  • Extracellular matrix
  • Scaffold material
  • Stem cell
  • Tissue engineering

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Furth, M. E., & Atala, A. (2013). Tissue Engineering: Future Perspectives. In Principles of Tissue Engineering: Fourth Edition (pp. 83-123). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-398358-9.00006-9

Tissue Engineering : Future Perspectives. / Furth, Mark E.; Atala, Anthony.

Principles of Tissue Engineering: Fourth Edition. Elsevier Inc., 2013. p. 83-123.

Research output: Chapter in Book/Report/Conference proceedingChapter

Furth, ME & Atala, A 2013, Tissue Engineering: Future Perspectives. in Principles of Tissue Engineering: Fourth Edition. Elsevier Inc., pp. 83-123. https://doi.org/10.1016/B978-0-12-398358-9.00006-9
Furth ME, Atala A. Tissue Engineering: Future Perspectives. In Principles of Tissue Engineering: Fourth Edition. Elsevier Inc. 2013. p. 83-123 https://doi.org/10.1016/B978-0-12-398358-9.00006-9
Furth, Mark E. ; Atala, Anthony. / Tissue Engineering : Future Perspectives. Principles of Tissue Engineering: Fourth Edition. Elsevier Inc., 2013. pp. 83-123
@inbook{0ba722cd21eb477ebdabf5e8524b8262,
title = "Tissue Engineering: Future Perspectives",
abstract = "Tissue engineering combines the principles of materials and cell transplantation to develop substitute tissues and/or promote endogenous regeneration. The approach was initially conceived to address the critical gap between the growing number of patients on the waiting list for organ transplantation, but it will focus increasingly on prevalent conditions in which the restoration of functional tissue would answer a currently unmet medical need. Significant progress has been realized since its inception, but to date only a handful of complex products incorporating cells together with scaffolds have gained regulatory approval, and these have only achieved limited market penetration. Nonetheless, recent clinical reports with multiple years of patient follow-up document the maturation of the field and validate the development of neo-tissues and neo-organs, and the industry is rapidly becoming economically robust. The combination of advances in both clinical development and commercialization indicates that these technologies will reach increasing numbers of patients in the years to come.",
keywords = "Biomaterial, Cell-seeded scaffold, Decellularized tissue, Extracellular matrix, Scaffold material, Stem cell, Tissue engineering",
author = "Furth, {Mark E.} and Anthony Atala",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/B978-0-12-398358-9.00006-9",
language = "English",
isbn = "9780123983589",
pages = "83--123",
booktitle = "Principles of Tissue Engineering: Fourth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Tissue Engineering

T2 - Future Perspectives

AU - Furth, Mark E.

AU - Atala, Anthony

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Tissue engineering combines the principles of materials and cell transplantation to develop substitute tissues and/or promote endogenous regeneration. The approach was initially conceived to address the critical gap between the growing number of patients on the waiting list for organ transplantation, but it will focus increasingly on prevalent conditions in which the restoration of functional tissue would answer a currently unmet medical need. Significant progress has been realized since its inception, but to date only a handful of complex products incorporating cells together with scaffolds have gained regulatory approval, and these have only achieved limited market penetration. Nonetheless, recent clinical reports with multiple years of patient follow-up document the maturation of the field and validate the development of neo-tissues and neo-organs, and the industry is rapidly becoming economically robust. The combination of advances in both clinical development and commercialization indicates that these technologies will reach increasing numbers of patients in the years to come.

AB - Tissue engineering combines the principles of materials and cell transplantation to develop substitute tissues and/or promote endogenous regeneration. The approach was initially conceived to address the critical gap between the growing number of patients on the waiting list for organ transplantation, but it will focus increasingly on prevalent conditions in which the restoration of functional tissue would answer a currently unmet medical need. Significant progress has been realized since its inception, but to date only a handful of complex products incorporating cells together with scaffolds have gained regulatory approval, and these have only achieved limited market penetration. Nonetheless, recent clinical reports with multiple years of patient follow-up document the maturation of the field and validate the development of neo-tissues and neo-organs, and the industry is rapidly becoming economically robust. The combination of advances in both clinical development and commercialization indicates that these technologies will reach increasing numbers of patients in the years to come.

KW - Biomaterial

KW - Cell-seeded scaffold

KW - Decellularized tissue

KW - Extracellular matrix

KW - Scaffold material

KW - Stem cell

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84903246585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903246585&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-398358-9.00006-9

DO - 10.1016/B978-0-12-398358-9.00006-9

M3 - Chapter

AN - SCOPUS:84903246585

SN - 9780123983589

SP - 83

EP - 123

BT - Principles of Tissue Engineering: Fourth Edition

PB - Elsevier Inc.

ER -